Search all trials

Find therapies in clinical trials near you – page 32

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis+1

Not recruiting

Registered drugNo placebo

Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azathioprine

Contact Research Centre

Malignant melanoma+1

Not recruiting

Registered drugNo placebo

Study Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Cardiac operation

Not recruiting

Registered drugNo placebo

Study on the Effect of Ropivacaine on Breathing After Heart Surgery for Patients Undergoing Cardiac Surgery

Registered drugNo placebo

France

Participants:18–64 years
Substances:Ropivacaine

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Pneumonia

Not recruiting

Registered drug

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Amikacin

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Registered drug

France

Participants:18–64 years · 65+ years

Contact Research Centre

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Investigational

France

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Uveitis

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Baricitinib

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Celecoxib

Contact Research Centre

Find therapies in clinical trials near you – page 32

454 trials match your criteria

Diffuse large B-cell lymphoma

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Anti-neutrophil cytoplasmic antibody positive vasculitis+1

Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

Malignant melanoma+1

Study Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma

B-cell lymphoma+1

Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

Cardiac operation

Study on the Effect of Ropivacaine on Breathing After Heart Surgery for Patients Undergoing Cardiac Surgery

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Pneumonia

Study on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection

Non-small cell lung cancer+2

Study on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab

Uveitis

Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

Myelofibrosis+1

Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.